93. Human-centric data and AI for improved drug development, David Berry, Founder & CEO, Valo Health
Biotech 2050 Podcast
00:00
The Problem of Alsheimers
I'm really excited by what's ahead over the next several decades, and our ability to pull talent from the silcon valley companies of the world to flagship portfolio companies. I think we all agree that solving alsheimers is a lot more of an pacful problem than, say, doing better adplacement. And those solutions can benefit perhaps the person who's working on it, perhaps their family, perhaps someone they've known, but also society at large.
Transcript
Play full episode
